Overview
Leishman–Donovan bodies are the intracellular amastigote forms of Leishmania parasites seen within macrophages of infected individuals. They are small, round to oval, non-flagellated organisms and represent the tissue stage of the parasite in humans. LD bodies are classically associated with Leishmania donovani, the causative agent of visceral leishmaniasis, also known as kala-azar. Demonstration of LD bodies in tissue samples remains a definitive method for diagnosing leishmaniasis.
Symptoms
Patients with infections showing LD bodies commonly present with prolonged fever, weight loss, fatigue, and loss of appetite. Visceral leishmaniasis is characterized by massive splenomegaly, hepatomegaly, anemia, and pancytopenia.
Skin manifestations may be seen in cutaneous or post–kala-azar dermal leishmaniasis, presenting as nodules, papules, or patches. Chronic disease can lead to severe wasting and increased susceptibility to secondary infections.
Causes
LD bodies are caused by infection with Leishmania species transmitted through the bite of infected female sandflies. After entering the human host, the parasites are phagocytosed by macrophages and transform into amastigotes, which multiply intracellularly. These amastigote forms, known as LD bodies, can be demonstrated in bone marrow aspirates, splenic aspirates, lymph nodes, or buffy coat preparations. Their presence indicates active leishmanial infection.
Risk Factors
Risk factors for leishmaniasis include residence in or travel to endemic areas, poor housing conditions, malnutrition, and immunosuppression. Children, individuals with HIV infection, and those with weakened immune systems are at higher risk of severe disease. Environmental exposure to sandflies and a lack of vector control measures increase transmission risk.
Prevention
Prevention of leishmaniasis focuses on reducing exposure to sandfly bites through vector control, use of insecticide-treated nets, and protective clothing. Early diagnosis by detection of LD bodies and prompt treatment reduces disease severity and transmission. Public health measures, improved living conditions, and surveillance in endemic regions play an important role in preventing outbreaks and long-term complications.
